Cadmium, follicle-stimulating hormone, and effects on bone in women age 42–60 years, NHANES III
- 31 January 2010
- journal article
- Published by Elsevier BV in Environmental Research
- Vol. 110 (1), 105-111
- https://doi.org/10.1016/j.envres.2009.09.012
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Lean Body Mass, Not Estrogen or Progesterone, Predicts Peak Bone Mineral Density in Premenopausal Women –Journal of Nutrition, 2009
- Cadmium exerts toxic effects on ovarian steroid hormone release in ratsToxicology Letters, 2008
- Cadmium-induced decrease in RUNX2 mRNA expression and recovery by the antioxidant N-acetylcysteine (NAC) in the human osteoblast-like cell line, Saos-2Toxicology in Vitro, 2008
- Urinary Cadmium and Osteoporosis in U.S. Women ≥50 Years of Age: NHANES 1988–1994 and 1999–2004Environmental Health Perspectives, 2008
- Bone Resorption and Environmental Exposure to Cadmium in Women: A Population StudyEnvironmental Health Perspectives, 2008
- Unraveling estrogen action in osteoporosisCell Cycle, 2008
- Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survivalThe EMBO Journal, 2008
- Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formationProceedings of the National Academy of Sciences of the United States of America, 2006
- Damage to ovarian development and functionCell and tissue research, 2005
- Disorders in bone metabolism of female rats chronically exposed to cadmiumToxicology and Applied Pharmacology, 2005